ETFs that hold Halozyme Therapeutics Inc
30 US listed ETFs hold Halozyme Therapeutics Inc. FBT holds the most, at 4.57% of the fund.
Every fund that holds it
| Fund | Name | Share of the fund | Holdings filed |
|---|---|---|---|
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 4.57% | Sep 18, 2026 |
| CANC | Tema Oncology ETF | 3.20% | Sep 18, 2026 |
| PBE | Invesco Biotechnology & Genome ETF | 2.91% | Sep 19, 2026 |
| BMED | iShares Health Innovation Active ETF | 2.03% | Sep 17, 2026 |
| BBP | Virtus Biotech ETF | 1.64% | Apr 30, 2026 |
| XBI | State Street SPDR S&P Biotech ETF | 1.49% | Sep 17, 2026 |
| ILDR | First Trust Innovation Leaders ETF | 1.03% | Sep 18, 2026 |
| IBB | iShares Biotechnology ETF | 0.93% | Sep 17, 2026 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.89% | Sep 19, 2026 |
| AGNG | Global X Aging Population ETF | 0.89% | Sep 18, 2026 |
| WDNA | WisdomTree BioRevolution Fund | 0.65% | Jun 30, 2026 |
| ETHO | Amplify Etho Climate Leadership U.S. ETF | 0.52% | Sep 21, 2026 |
| ABOT | Abacus FCF Innovation Leaders ETF | 0.41% | Apr 30, 2026 |
| IJH | iShares Core S&P Mid-Cap ETF | 0.37% | Sep 17, 2026 |
| MDY | SPDR S&P MidCap 400 ETF Trust | 0.37% | Sep 17, 2026 |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | 0.36% | Aug 31, 2026 |
| VHT | Vanguard Health Care ETF | 0.17% | Aug 31, 2026 |
| VB | Vanguard Morningstar Small-Cap ETF | 0.15% | Aug 31, 2026 |
| VXF | Vanguard Extended Market ETF | 0.15% | Aug 31, 2026 |
| DYNF | iShares U.S. Equity Factor Rotation Active ETF | 0.04% | Sep 17, 2026 |
| IWF | iShares Russell 1000 Growth ETF | 0.04% | Sep 17, 2026 |
| VONG | Vanguard Russell 1000 Growth ETF | 0.04% | Aug 31, 2026 |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.02% | Sep 17, 2026 |
| IWB | iShares Russell 1000 ETF | 0.02% | Sep 17, 2026 |
| AVUS | Avantis U.S. Equity ETF | 0.02% | May 31, 2026 |
| VTI | Vanguard Morningstar Total Stock Market ETF | 0.02% | Aug 31, 2026 |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.02% | May 31, 2026 |
| DFUS | Dimensional U.S. Equity Market ETF | 0.01% | Apr 30, 2026 |
| SCHB | Schwab U.S. Broad Market ETF | 0.01% | Jun 30, 2026 |
| VT | Vanguard Total World Stock Index ETF | 0.01% | Aug 31, 2026 |
What this counts
Halozyme Therapeutics Inc (ticker HALO) is matched across every holdings book ETFIQ publishes, by its ticker together with its name. A share of the fund is the weight the issuer itself published, as of the date in the last column. Option contracts, swaps, futures, cash and money market holdings are not counted as holding a company: a fund holding a call option on a share does not hold the share. Funds whose published book is gross exposure rather than a portfolio are left out entirely, because a weight in such a book is not a share of anything.
Holdings change. Each row carries the date the fund last filed, and a fund that files quarterly can have traded since.
Cite this page. ETFIQ, ETFs holding Halozyme Therapeutics Inc, data as of Sep 21, 2026. https://etfiq.com/holdings/halo/ Free to use with attribution; the underlying files are at Open data.